Immune mechanisms of protection against Mycobacterium tuberculosis‐centers

Que Dang,Katrin Eichelberg,Nancy Vázquez-Maldonado,César Boggiano,Wolfgang W. Leitner,Lakshmi Ramachandra,Alison Deckhut-Augustine,Sarah W. Read
DOI: https://doi.org/10.3389/fimmu.2024.1429250
IF: 7.3
2024-10-08
Frontiers in Immunology
Abstract:As one of the world's largest funders of biomedical research on TB, the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIAID, NIH) has prioritized investing in TB to save lives. Specifically, NIAID supports and conducts basic, translational, and clinical research to better understand TB and expedite the development of innovative new tools and strategies to improve diagnosis, prevention and treatment of TB. Although all three centers are pursuing distinct goals and addressing different research questions, collectively they conduct analyses on tissue-specific and systemic immune responses in small animals, nonhuman primates (NHPs), and humans to identify and to characterize the immunological space associated with protection and susceptibility to Mtb. Interestingly, the different approaches used by the centers are leading to the identification of converging themes that may play a role in protection and/or susceptibility.Other select highlights and contributions by the Centers are:• Development of the first clinical trial employing a controlled human infection model to test the efficacy of a TB vaccine candidate. Participants will be challenged with aerosolized BCG. This clinical trial is expected to start at the end of 2024.• Cross-species comparison to define immune mechanisms for prevention of infection or disease using mice, including Collaborative Cross mice, guinea pigs, NHPs, and humans.• Ultra-low dose challenge model in small animals and in NHPs.• Back-translation, refinement, and validation of preclinical models with human data to improve their predictive value.• Validation of newly developed guinea pig-specific immunological reagents to be offered to the field.• Development of novel analytical frameworks for integration of complex and multi-modal profiling data sets that will advance identification of correlates of protection across species.The subsequent articles in this issue of Frontiers exemplify additional work by the three Centers.
immunology
What problem does this paper attempt to address?